Host factors causing increased susceptibility to infection in patients with Laennec's cirrhosis.
D000380:Agranulocytosis / Q000150:complications; D000437:Alcoholism / Q000150:complications*; D000907:Antibodies, Bacterial; D000917:Antibody Formation; D001770:Blood Bactericidal Activity / Q000187:drug effects; D002633:Chemotaxis / Q000187:drug effects; D003176:Complement C3 / Q000172:deficiency; D003181:Complement C4 / Q000172:deficiency; D006098:Granulocytes / Q000187:drug effects; D006801:Humans; D007239:Infections / Q000209:etiology*; D008099:Liver / Q000503:physiopathology; D008103:Liver Cirrhosis / Q000150:complications* / Q000209:etiology / Q000503:physiopathology; D016031:Liver Transplantation; D010586:Phagocytes / Q000187:drug effects
D000907:Antibodies, Bacterial; D003176:Complement C3; D003181:Complement C4